2022 Heart Failure Update by major Medical Societies
Welcome to Guardsman Scientific
Patients with Heart Failure or at risk of developing Heart Failure welcome new patient-specific management guideline.
About Us
Better Data = A Better Way
Guardsman Scientific, Inc. is a new generation HealthTech company focused on using patient-specific data points for better outcomes at lower costs. Guardsman Scientific continues developing unique, data-driven, noninvasive methods and systems designed to identify, monitor and manage patients with serious medical conditions. Heart Failure (HF) has been an early focus of interest and success for Guardsman Scientific.
Heart Failure Update
Heart Failure Update from Medical Societies
"Patient-centric recommendations" to help clinicians prevent, diagnose and treat heart failure (HF) are the focus of a new 2022 clinical guideline released by the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America.
The joint 2022 Guideline for the Management of HF includes a focus on HF prevention, with revised definitions of Stage A and Stage B HF intended to identify risk factors early (Stage A) and provide treatment before structural changes or signs of decreased HF occur (Stage B).